By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Anadys Pharmaceuticals, Inc. 

3115 Merryfield Row

San Diego  California  92121  U.S.A.
Phone: 858-530-3600 Fax: 858-527-1540


SEARCH JOBS



Segment
Drug Discovery





Company News
Anadys Pharmaceuticals, Inc. (ANDS) Reports Third Quarter 2011 Financial Results and Highlights 11/7/2011 3:22:13 PM
Faruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc. (ANDS) 10/20/2011 11:43:54 AM
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals, Inc. (ANDS) in Connection with the Sale of the Company to Roche Holding AG (RHHBF.PK) 10/17/2011 1:49:30 PM
Roche (RHHBY) Buys Anadys Pharmaceuticals, Inc. (ANDS) for $230 Million to Boost Hepatitis Ops 10/17/2011 7:30:46 AM
Anadys Pharmaceuticals, Inc. (ANDS) Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study 10/13/2011 6:47:12 AM
Anadys Pharmaceuticals, Inc. (ANDS) to Present at Two Upcoming Investor Conferences 9/16/2011 6:03:47 AM
Anadys Pharmaceuticals, Inc. (ANDS)' Setrobuvir Named One of Windhover's Top 10 Most Interesting Infectious Disease Projects to Watch 9/8/2011 5:41:54 AM
Anadys Pharmaceuticals, Inc. (ANDS) Updates Its Presentation Date at the Stifel Nicolaus Healthcare Conference 9/7/2011 5:36:11 AM
Anadys Pharmaceuticals, Inc. (ANDS) to Present at Two Upcoming Investor Conferences 9/2/2011 5:56:06 AM
Anadys Pharmaceuticals, Inc. (ANDS) Appoints Brian S. Posner to Its Board of Directors 8/23/2011 5:46:48 AM
12345678910...
//-->